Skip to content

A study to see how safe a new medicine (NNC6022-0004) is in healthy people and people living with obesity

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525179-26-00
Enrollment
128
Registered
2026-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 20, 2026